CytomX Therapeutics Inc (CTMX) — Cash Flow Reinvestment Rate
CytomX Therapeutics Inc (CTMX) has a Cash Flow Reinvestment Rate of 15.69x as of March 2023, reinvesting $146.64 Million (capex $48.00K plus investments $-146.59 Million) from operating cash flow of $9.35 Million. Check CytomX Therapeutics Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
CytomX Therapeutics Inc Cash Flow Reinvestment Rate (2014–2020)
Historical reinvestment intensity for CytomX Therapeutics Inc across 3 annual periods. Explore CytomX Therapeutics Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for CytomX Therapeutics Inc (2014–2020)
Year-by-year capital reinvestment analysis for CytomX Therapeutics Inc. For live market cap and broader valuation context, see CytomX Therapeutics Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 3.56x | $18.72 Million | $5.26 Million | $2.31 Million | ▲ +393.7% |
| 2017 | 0.72x | $122.83 Million | $170.37 Million | $1.56 Million | ▼ -82.3% |
| 2014 | 4.08x | $129.81 Million | $31.80 Million | $1.66 Million | — |